A Phase 2 Randomized, Double-Blind, Placebo-Controlled, DoseFinding Study to Investigate Safety, Tolerability, Pharmacokinetics, and Efficacy of NBI-921352 as Adjunctive Therapy in Adult Subjects with Focal Onset Seizures (FOS)

Project: Research

Project Details

StatusFinished
Effective start/end date10/05/22 → 10/04/24

Keywords

  • Clinical trial
  • Pharmacokinetics
  • Focal seizures